prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype Basal, Specimen #: Race: BLACK. Physician( (s) : SPECIMEN: A: LEFT BREAST B: SKIN FLAP. FINAL DIAGNOSIS: A. BREAST, LEFT, MASTECTOMY WITH AXILLARY TAIL: TUMOR TYPE: INFILTRATING DUCTAL CARCINOMA, NO SPECIAL TYPE. NOTTINGHAM GRADE: POORLY DIFFERENTIATED (G3). NOTTINGHAM SCORE: 9 (Tubules= 3, Nuclei= 3, Mitoses= 3 mitotic count. > 12 per 10 HPF at 40x power). TUMOR SIZE (GREATEST DIMENSION) : 3.5 CM. (MEASURED GROSSLY) . TUMOR NECROSIS: PRESENT IN INFILTRATING COMPONENT. MICROCALCIFICATIONS: ABSENT. VENOUS / LYMPHATIC INVASION: ABSENT. MARGINS : NEGATIVE. -DISTANCE OF TUMOR FROM NEAREST MARGIN IS 2.0 CM. (DEEP MARGIN) . INTRADUCTAL COMPONENT: ABSENT. LYMPH NODES: TEN (10) LYMPH NODES NEGATIVE FOR TUMOR. NIPPLE INVOLVEMENT: ABSENT. SKIN INVOLVEMENT: ABSENT. MULTICENTRICITY: ABSENT. ESTROGEN RECEPTORS: NEGATIVE (REFER TO PRIOR SPECIMEN. PROGESTERONE RECEPTORS: NEGATIVE (REFER TO PRIOR SPECIMEN. HER 2 NEU by IHC: NEGATIVE, 1+ (REFER TO PRIOR SPECIMEN. PATHOLOGIC STAGE: pT2 NO MX. ADDITIONAL PATHOLOGIC FINDINGS: - PERIDUCTAL CHRONIC INFLAMMATION. B. SKIN, LEFT BREAST, EXCISION: - -UNREMARKABLE SKIN AND SUBCUTANEOUS SOFT TISSUE. - -NO EVIDENCE OF MALIGNANCY. 1. Specimen #: CLINICAL DIAGNOSIS AND HISTORY: -year-old - female with breast cancer. PRE-OPERATIVE DIAGNOSIS: Breast cancer. GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. designated "LEFT BREAST" is a 1. 466 gram, left mastectomy specimen. oriented with a short stitch superior, long lateral, and double deep. The. specimen measures 31.0 cm medial to lateral, 23.0 cm superior to inferior,. and 6.0 cm anterior to posterior. The darkly pigmented, superficial. skin. ellipse measures 30.0 x 6.0 cm, and displays a 1.0 cm everted, centrally. located, nipple free of discharge. No scars are noted. The deep margin. is remarkable for scattered, irregular portion of attached red-brown. muscle measuring up to 4.5 x 1.5 cm in greatest dimension. The deep. margin is inked in black, and the superficial-lateral surface is inked. blue. Serial sections reveal a 3.5 x 2.8 x 3.0 cm poorly defined mass in. the mid-outer breast. On sectioning, the cut surface ranges from. pink-white, and firm, to pink-white, soft, and cystic. Continuous, with,. and deep to, this mass is a 2.0 x 2.0 x 1.9 cm smooth walled cyst. containing serosanguineous fluid, consistent with the previous biopsy. site. The cyst and mass are located 2.0 cm from the deep margin. The. remainder of the specimen is predominantly composed of lobulated,. yellow-tan, adipose tissue admixed with scant, fibrous tissue. No. additional lesions are identified. Specimen subsequently placed in. formalin for 32 hours. The attached axillary tail measures 13.0 x 9.0 x 3.0 cm. On sectioning,. eight pink-tan, lymph nodes are identified which range in size from 0.8 x. 0. x 0.2 cm to 3.0 x 2.0 x 1.0 cm. Representative sections are. submitted. Cassette Summary: A1: Skin. A2: Mass. A3: Mass. A4: Mass and adjacent cyst. A5: Normal adjacent to mass. A6-A7: Deep margin closest to mass. A8: Upper outer quadrant . A9: Upper inner quadrant . A10: Lower outer quadrant . All: Lower inner quadrant. Specimen #: GROSS DESCRIPTION (continued). A12: Largest lymph node. A13-A14: - Second largest lymph node. A15-A16 One lymph node. A17: Three lymph nodes. A18: One lymph node bisected. A19: One lymph node bisected. A20: Nipple. Matched sections of A1 through A3, A8 through A12, A13, A15, A20 are. submitted in OCT for CBCP protocol. 20CF. B. Received in formalin for twenty-eight hours, labeled with the patient's. designated "SKIN FLAP" is an irregular, lobular. fragment of soft tissue with attached brown skin forming a continuous ring. which measures 61.0 cm in circumference with the width of skin ranging. from 1.5 cm at narrowest to 4.8 cm at widest. No lesions are seen on the. skin surface. Representative sections are submitted in one cassette. 1CF.

expanded version (tokens=1602) : 
 The breast pathology report indicates that the patient has infiltrating ductal carcinoma, no special type, with a subtype basal. The tumor is poorly differentiated (G3) with a size of 3.5 cm and presence of necrosis in the infiltrating component. There is no evidence of microcalcifications or venous/lymphatic invasion. The histological grade is determined to be Nottingham score 9, with tubules = 3, nuclei = 3, mitoses = 3 and a mitotic count of > 12 per 10 HPF at 40x power. There is no intraductal component, lymphovascular invasion, or nipple/skin involvement. Multicentricity is absent and lymph nodes are negative for tumor. The estrogen receptors (ER) and progesterone receptors (PR) are negative and HER2NEU by IHC is negative (1+). The pathological stage is pT2 NO MX. Additional pathologic findings show periductal chronic inflammation. The skin flap excision is unremarkable with no evidence of malignancy.

To summarize, the main points from the breast pathology report are:

- Subtype Basal, infiltrating ductal carcinoma no special type
- Histological grade is determined to be poorly differentiated (G3), Nottingham score 9
- Tumor has a size of 3.5 cm with the presence of necrosis in the infiltrating component
- No evidence of microcalcifications

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1762) : 
 Breast pathology report for a Black female shows subtype basal infiltrating ductal carcinoma no special type. Tumor is poorly differentiated with necrosis present, but microcalcifications are absent. No venous/lymphatic invasion or intraductal component found. Nottingham score is 9 and there is no nipple/skin involvement, lymphovascular invasion, or multicentricity. The tumor is ER/PR negative and HER2NEU negative (1+). Pathological stage is pT2 NO MX with periductal chronic inflammation observed.

